Stock listing

OTC:MTST MetaStat Inc Stock

Follow MetaStat Inc into a list and get an email when it puts out news.

Share price · OTC:MTST

$0.0007 USD 0.0000 (0.0%)

Close on Oct 23, 2026

Past year +250.0% · daily closes, Oct 23, 2025 – Oct 23, 2026, adjusted for splits
Day range
$0.0007 – $0.0007 USDOct 23, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.0001 – $0.0491 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Traded on an average day
$0 USDMedian day 0 shares · 65 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026
MetaStat Inc logo

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:MTST · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007-0.0003-30.0%$0.0007$0.0491$0.00074,200
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0001$0.0010$0.000116,900
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100

Splits

2 splits since 2011 · OTC:MTST · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
1-for-10Consolidation
Ticker
OTC:MTST
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All MetaStat Inc news

MetaStat Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in all · newest Jul 16, 2018 · oldest 2015
Decks
6 decks · latest Dec 4, 2015

Valuation

price Oct 23, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.07

Team and board

OfficerRole
Steven BartlettCo-founder
Tom LewisCo-founder

Events

QuarterResultsShare move
Quarter to Nov 30, 2024Jan 29, 20250.0%
Quarter to Aug 31, 2024Oct 30, 20240.0%
Quarter to May 31, 2024Jul 31, 20240.0%
Quarter to Feb 29, 2024May 1, 20240.0%
Quarter to Nov 30, 2023Jan 31, 20240.0%
Quarter to Aug 31, 2023Nov 1, 20230.0%
Quarter to May 31, 2023Aug 2, 20230.0%
Quarter to Feb 28, 2023May 3, 20230.0%
Quarter to Nov 30, 2022Feb 1, 20230.0%
Quarter to Aug 31, 2022Nov 2, 20220.0%
All 17 quarters
QuarterResultsShare move
Quarter to May 31, 2022Aug 3, 20220.0%
Quarter to Feb 28, 2022Apr 27, 20220.0%
Quarter to Nov 30, 2021Feb 2, 20220.0%
Quarter to Aug 31, 2021Nov 3, 20210.0%
Quarter to May 31, 2021Jul 28, 20210.0%
Quarter to Feb 28, 2021Apr 28, 20210.0%
Quarter to Nov 30, 2020Feb 3, 20210.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2015)Investor deck23 slidesDec 4, 2015
Investor Presentation (September 2015)Investor deck26 slidesSep 9, 2015
Investor Presentation (February 2015)Investor deck28 slidesFeb 26, 2015
Rodman & Renshaw 2014 Annual Global Investment ConferenceConference23 slidesSep 10, 2014
Investor Presentation (January 2014)Investor deck33 slidesJan 15, 2014
Investor Presentation (December 2012)Investor deck22 slidesDec 20, 2012

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015FY2014FY2013
Revenue23.3K0000
Cost of revenue1.26M1.01M000
Gross profit23.3K-1.01M000
Research and development1.26M1.01M1.36M1.27M824.3K516.8K
Selling, general and administrative2.32M2.34M3.42M3.52M3.53M1.76M
Operating income-3.55M3.35M4.78M4.79M4.35M2.52M
Depreciation and amortization228.5K236.6K206.3K171.9K89.2K95.8K96.2K61.9K21.8K11.1K
EBITDA-3.46M3.44M4.88M4.85M4.37M2.53M
Interest expense119.3K1.06M317.2K95.0K137.1K0
Income before tax-3.18M-2.94M-4.65M-8.00M-5.37M-2.52M
Income tax119.9K1.06M317.2K95.0K137.1K229.6K
Net income-3.18M-2.94M-4.65M-8.00M-5.37M-2.52M
Earnings per share, basic-0.59-0.99-2.56-4.81-3.80-1.81

Balance sheet

LineFY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015FY2014FY2013
Cash and equivalents316.9K782.7K363.8K257.8K483.4K969.2K
Receivables125.0K125.0K20.0K20.0K
Current assets331.9K803.6K521.9K296.6K576.0K969.2K
Property, plant and equipment354.1K414.6K497.1K526.6K205.0K54.0K
Total assets729.6K1.26M1.06M1.10M790.6K1.02M
Accounts payable571.6K571.6K572.2K746.1K293.2K258.0K
Current liabilities2.08M1.95M2.60M416.8K2.87M886.9K
Long-term debt170.0K
Total debt1.00M989.1K1.53M269.6K2.48M717.0K
Total liabilities2.28M4.06M2.83M859.5K2.87M886.9K
Shareholders' equity-1.55M-2.80M-1.77M242.7K-2.08M135.6K
Shares outstanding5.43M5.43M5.43M5.43M5.43M2.97M1.82M1.66M1.41M1.39M

Cash flow

LineFY2018FY2017FY2016FY2015FY2014FY2013
Cash from operations-2.74M-2.31M-3.14M-3.58M-2.20M-2.40M
Capital spending-30.1K-13.4K-151.8K-65.6K-172.7K-45.2K
Free cash flow-2.77M-2.33M-3.29M-3.65M-2.37M-2.44M
Cash from investing-30.1K-921-48.9K1.15M-172.7K-45.2K
Cash from financing2.31M2.73M3.30M2.21M1.89M2.53M
Share buybacks2.31M02.75M711.1K711.1K
Change in cash-465.8K418.9K106.0K-225.6K-485.8K90.8K

Open Financials

Cap table

Built by 6ix from MetaStat Inc’s releases

Common shares
5,877,383
Fully diluted
5,877,383

Fully diluted

LineShares
Common shares5,877,383

Share count over time

CountShares
Nov 22, 20265,877,383

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jerome Zeldis
Other companies: NexGel, Inc (Director · Since at least Mar 8, 2021); PTC Therapeutics, Inc. (Director · Since at least Jun 19, 2013); Soligenix, Inc. (Board Director · Since at least Jun 22, 2011); NexImmune, Inc. (Executive VP of Research & Dev · Feb 11, 2021 – Apr 5, 2022 · Past); Beyond Air, Inc. (Director · Mar 14, 2017 – Mar 14, 2017 · Past); Sorrento Therapeutics, Inc. (See Remarks · Aug 12, 2016 – Nov 26, 2018 · Past); Streamex Corp. (Director · Jul 20, 2015 – Jul 14, 2020 · Past)
Director · Oct 11, 2017 – Oct 11, 2017 · Past
Martin J Driscoll
Other companies: Spring Bank Pharmaceuticals Inc (President and CEO, Director · May 5, 2016 – Mar 5, 2020 · Past)
Director · Aug 5, 2015 – Aug 5, 2015 · Past
Paul Billings
Other companies: Cardiff Oncology, Inc. (Director · Oct 30, 2013 – Jan 23, 2018 · Past)
Director · May 24, 2017 – Oct 11, 2017 · Past
Douglas A HamiltonPRESIDENT AND CEO · Jun 17, 2015 – Oct 11, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about MetaStat Inc.